Aquestive Therapeutics SG&A Expense (TTM) Insights

Aquestive Therapeutics Inc (AQST)

2.335 -0.10 (-3.91%) USD | NASDAQ | Jun 26, 09:58

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	34.98M
December 31, 2023	31.75M
September 30, 2023	34.01M
June 30, 2023	39.09M
March 31, 2023	47.31M
December 31, 2022	52.88M
September 30, 2022	56.05M
June 30, 2022	55.72M
March 31, 2022	53.26M
December 31, 2021	53.48M
September 30, 2021	54.08M
June 30, 2021	53.75M
March 31, 2021	54.51M

Date	Value
December 31, 2020	55.89M
September 30, 2020	56.78M
June 30, 2020	58.70M
March 31, 2020	61.05M
December 31, 2019	64.34M
September 30, 2019	66.58M
June 30, 2019	65.21M
March 31, 2019	82.63M
December 31, 2018	72.29M
September 30, 2018	61.15M
June 30, 2018	54.96M
March 31, 2018	26.52M
December 31, 2017	25.08M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

31.75M

Minimum

Dec 2023

66.58M

Maximum

Sep 2019

52.47M

Average

54.29M

Median

SG&A Expense (TTM) Benchmarks